ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer

Jiang, Rui; Wang, Jinghua; Liang, Jun; Lin, Daihua; Mao, Qiuxian; Cheng, Siyi; Huang, Shengjun; Tong, Shuangshuang; Lyu, Yanlin; Wei, Rui; Lian, Qizhou*; Chen, Hao*广东省人民医院; 广州医学院; 汕头大学; 中国科学院
Frontiers in Pharmacology2023-1-11DOI: 10.3389/fphar.2022.1096055
9阅读
引用收藏
分享

摘要

Background: Gastric cancer (GC) is a multifactorial progressive disease with high mortality and heterogeneous prognosis. Effective prognostic biomarkers for GC were critically needed. Hippo signaling pathway is one of the critical mechanisms regulating the occurrence and development of GC, and has potential clinical application value for the prognosis and treatment of GC patients. However, there is no effective signature based on Hippo signaling pathway-related genes (HSPRGs) to predict the prognosis and treatment response of GC patients. Our study aimed to build a HSPRGs signature and explore its performance in improving prognostic assessment and drug therapeutic response in GC.Methods: Based on gene expression profiles obtained from The Cancer Genome Atlas (TCGA) database, we identified differentially expressed HSPRGs and conducted univariate and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis to construct a multigene risk signature. Subsequently, the Kaplan-Meier curve and receiver operating characteristic (ROC) were performed to evaluate the predictive value of the risk signature in both training and validation cohort. Furthermore, we carried out univariate and multivariate Cox regression analysis to investigate the independent prognostic factors and establish a predictive nomogram. The enriched signaling pathways in risk signature were analyzed by gene set enrichment analysis (GSEA). Tumor immune dysfunction and exclusion (TIDE) and drug sensitivity analysis were performed to depict therapeutic response in GC.Results: In total, 38 differentially expressed HSPRGs were identified, and final four genes (DLG3, TGFB3, TGFBR1, FZD6) were incorporated to build the signature. The ROC curve with average 1-, 3-, and 5-year areas under the curve (AUC) equal to .609, .634, and .639. Clinical ROC curve revealed that risk signature was superior to other clinicopathological factors in predicting prognosis. Calibration curves and C-index (.655) of nomogram showed excellent consistency. Besides, in the immunotherapy analysis, exclusion (p < 2.22 x 10(-16)) and microsatellite instability (p = .0058) performed significantly differences. Finally, our results suggested that patients in the high-risk group were more sensitive to specific chemotherapeutic agents.Conclusion: Results support the hypothesis that Hippo-related signature is a novel prognostic biomarker and predictor, which could help optimize GC prognostic stratification and inform clinical medication decisions.

学科与关键词

关键词
gastric cancerhippo signaling pathwayprognostic predictiondrug sensitivity analysistherapeutic response
相关
加载中…
  • Comprehensive Analysis on Prognostic Signature Based on T Cell-Mediated Tumor Killing Related Genes in Gastric Cancer
    Zhai, Jiabao; Nie, Chuang; Wang, Wanyu; Liu, Chang; Liu, Tianyu; Sun, Lishuang; Li, Wei; Wang, Wentong; Ren, Xiyun; Han, Xu; Zhou, Haibo; Li, Xin; Tian, Wenjing*Biochemical Genetics, 2024, 62(1): 504-529.
  • Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
    Wang, Qian; Li, Xiangmei; Wang, Yahui; Qiu, Jiayue; Wu, Jiashuo; He, Yalan; Li, Ji; Kong, Qingfei*; Han, Junwei*; Jiang, Ying*Frontiers in Genetics, 2022, 12: 801240.被引 4
  • Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer
    Dai, Weiyu; Xiao, Yizhi; Tang, Weimei; Li, Jiaying; Hong, Linjie; Zhang, Jieming; Pei, Miaomiao; Lin, Jianjiao; Liu, Side; Wu, Xiaosheng*; Xiang, Li*; Wang, Jide*Frontiers in Genetics, 2021, 12: 661306.被引 20
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-01-11
卷期
第 13 卷
页码
1096055
DOI
10.3389/fphar.2022.1096055
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82171698, 81300279, 81741067, 82100238]; Natural Science Foundation for Distinguished Young Scholars of Guangdong Province [2021B1515020003]; Climbing Program of Introduced Talents and High-level Hospital Construction Project of Guangdong Provincial People's Hospital [KJ012019099, KJ012021143, KY012021183]; Science and Technology Program of Guangzhou [202201011046]

作者

  • J

    Jiang, Rui (第一作者)

    guangdong prov peoples hosp

  • W

    Wang, Jinghua

    guangdong prov peoples hosp

查看全部 12 位作者收起作者
  • L

    Liang, Jun

    guangdong prov peoples hosp

  • L

    Lin, Daihua

  • M

    Mao, Qiuxian

  • C

    Cheng, Siyi

  • H

    Huang, Shengjun

  • T

    Tong, Shuangshuang

    shantou univ

  • L

    Lyu, Yanlin

    shantou univ

  • W

    Wei, Rui

    guangdong prov peoples hosp · univ hong kong

  • L

    Lian, Qizhou (通讯)

    chinese acad sci · univ hong kong · guangzhou med univ · guangzhou women & childrens med ctr

  • C

    Chen, Hao (通讯)

    guangdong prov peoples hosp · shantou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417